 CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Jan. 07, 2022 GLOBE NEWSWIRE -- F-star Therapeutics, Inc. NASDAQ: FSTX, a clinical-stage biopharmaceutical company dedicated to developing next-generation bispecific immunotherapies to transform the lives of patients with cancer, today announced that it will participate in the H.C. Wainwright Bioconnect Conference and the B. Riley Securities 2022 Oncology Conference taking place virtually on January 10-13, and January 27-28, 2022, respectively. 